Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. (FNCH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FNCH · as of Jun 9, 2026
Key Statistics
Explore Finch Therapeutics Group, Inc. Data
fnch stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The FNCH analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $159.98, representing +2047.38% upside from the current price of $7.45.
Competitors & Peers
fnch competitorsFNCH
BBIXF
CLYYF
CWBHF
ELVAF
MEDIFStock Performance
Full HistoryAbout Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. is a U.S.-based, clinical-stage biotechnology company dedicated to developing innovative, orally administered biological drugs that leverage the microbiome. Its leading …
what is finch therapeutics group, inc. · fnch stock overview · finch therapeutics group, inc. company profile · who is finch therapeutics group, inc. ceo · fnch OTC · finch therapeutics group, inc. headquarters · finch therapeutics group, inc. business segments
About Stock Overview & Key Data
Finch Therapeutics Group, Inc. (FNCH) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 19, 2021. As of the latest trading session, FNCH stock price is $7.45, with a market capitalization of $12.0M. The stock has returned -44.36% over the past 12 months and -44.77% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Finch Therapeutics Group, Inc. stock is Buy, with an average 12-month price target of $159.98. In fiscal year 2024, Finch Therapeutics Group, Inc. reported revenue of — and net income of -$13.9M. For detailed data — including Finch Therapeutics Group, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Finch Therapeutics Group, Inc. (FNCH) stock price is $7.45. The stock is traded on OTC under the ticker symbol FNCH. The 52-week range is $2.00 – $16.10.